Valuation : Aligned Genetics, Inc.

Market Cap 42.16B 30.73M 26.51M 24.93M 22.72M 42.72M 2.92B 42.95M 295M 115M 1.48B 115M 113M 4.92B P/E 2024
10.5x
P/E 2025 18.8x
Enterprise Value 42.04B 30.65M 26.44M 24.87M 22.66M 42.6M 2.91B 42.83M 294M 114M 1.48B 115M 113M 4.91B EV / Sales 2024
1.83x
EV / Sales 2025 3.39x
Free-Float
58.64%
Yield 2024 *
-
Yield 2025 -
1 day-2.47%
1 week-0.50%
Current month-2.47%
1 month+3.67%
3 months-14.55%
6 months-38.93%
Current year-23.39%
1 week 2,855
Extreme 2855
3,050
1 month 2,600
Extreme 2600
3,310
Current year 2,380
Extreme 2380
6,050
1 year 2,380
Extreme 2380
6,050
3 years 2,380
Extreme 2380
6,175
5 years 2,380
Extreme 2380
6,500
10 years 2,002.5
Extreme 2002.5
9,150
Manager TitleAgeSince
Chief Executive Officer 56 01/10/2008
Corporate Officer/Principal 53 01/03/2012
Corporate Officer/Principal 58 01/10/2008
Director TitleAgeSince
Director/Board Member 58 01/10/2008
Director/Board Member 56 01/10/2008
Director/Board Member 53 01/03/2012
Change 5-day change 1-year change 3-year change Capi.($)
-2.47%-0.50%-7.63%-31.21% 30.73M
-2.27%-0.90%+23.79%-34.87% 17.71B
-0.44%-7.58%-36.42%+54.88% 1.6B
-4.71%-8.64%-52.07%-83.56% 943M
-1.45%-1.46%-23.54%+16.91% 947M
-0.11%-0.16%+59.91%-7.37% 778M
+2.40%+0.09%-33.29%-45.77% 690M
+2.07%+8.62%-38.78%-46.21% 611M
-1.47%+9.60%-30.97%-32.52% 502M
-0.19%-3.18%+70.40%+49.79% 440M
Average -0.86%+0.22%-6.86%-15.99% 2.42B
Weighted average by Cap. -1.85%-0.14%+12.66%-26.96%

Financials

2024 2025
Net sales 15.78B 11.5M 9.92M 9.33M 8.5M 15.99M 1.09B 16.07M 110M 42.94M 555M 43.18M 42.24M 1.84B 16.02B 11.67M 10.07M 9.47M 8.63M 16.23M 1.11B 16.32M 112M 43.59M 564M 43.83M 42.88M 1.87B
Net income 4.13B 3.01M 2.6M 2.44M 2.22M 4.18M 286M 4.21M 28.86M 11.23M 145M 11.3M 11.05M 482M 2.91B 2.12M 1.83M 1.72M 1.57M 2.95M 201M 2.97M 20.36M 7.92M 102M 7.97M 7.8M 340M
Net Debt -14.68B -10.7M -9.23M -8.68M -7.91M -14.87M -1.02B -14.95M -103M -39.94M -516M -40.16M -39.29M -1.71B -113M -82.38K -71.06K -66.84K -60.9K -115K -7.82M -115K -790K -308K -3.98M -309K -303K -13.19M
Logo Aligned Genetics, Inc.
Aligned Genetics Inc, formerly Logos Biosystems Inc, is a Korea-based company engaged in the manufacture and sale of medical equipment. The Company's products mainly consist of automated cell counters, such as LUNA, LUNA-FL, LUNA-STEM, LUNA-II, LUNA- YF, QUANTOM, tissue clearing systems, such as X-CLARITY, and digital cell imaging systems, such as iRiS.
Employees
-
Date Price Change Volume
01/09/26 ₩2,965.00 -2.47% 13,743
31/08/26 ₩3,040.00 +2.01% 4,482
28/08/26 ₩2,980.00 +1.88% 8,424
27/08/26 ₩2,925.00 -1.68% 47,134
26/08/26 ₩2,975.00 -0.17% 7,085
  1. Stock Market
  2. Stocks
  3. A238120 Stock